NOF Statement on Medicare Part B »

| Advocacy, NOF in the News

Washington, DC (October 25, 2018) – The National Osteoporosis Foundation issued the following statement regarding announced changes the Medicare Part B program: “Medicare Part B is vital to patients living with and managing chronic illnesses, like osteoporosis. Key to treatment under the program is the ability for doctors and patients to tailor care to the… Read more »

NOF Statement On Medicare Open Enrollment »

| Advocacy, NOF in the News, Press Releases

Patient Group Urges Fix To DXA Screening Reimbursement Rates To Encourage More Osteoporosis Screenings Today, as Medicare Open Enrollment starts, the National Osteoporosis Foundation (NOF) urged policymakers to raise the reimbursement rates for x-ray absorptiometry (DXA) screenings, which are the gold standard for osteoporosis screenings. Currently, bipartisan bills are sitting in both Chambers that would… Read more »

NPR Article: Wider Use Of Osteoporosis Drug Could Prevent Bone Fractures In More Elderly Women »

| NOF in the News, Osteoporosis in the News

In response to a recent NPR article detailing the positive results of a common osteoporosis drug, Elizabeth Thompson, NOF, CEO, said:  “When the experts in the field say that this study is “extremely important”, “highly effective”, and “a breakthrough”, we are making progress! Reducing suffering and maintaining life quality is important for our senior population—key… Read more »

NOF Named an Official Charity Partner of the TCS New York City Marathon and Fields a Team of Runners Aged 40+ »

| NOF in the News, Osteoporosis in the News, Press Releases

The National Osteoporosis Foundation (NOF), the leading bone health organization in the U.S., was named an Official Charity Partner of the 2018 TCS New York City Marathon. The race will take place on Sunday, November 4, 2018. For its inaugural team, NOF has secured five women over the age of 40 to join its Be… Read more »

Leading Organizations Meet To Discuss Unmet Needs In Osteoporosis and Outline An Initial Action Plan »

| NOF in the News, Osteoporosis in the News, Press Releases

June 11, 2018| Press Releases On June 11, 2018, leaders from the National Osteoporosis Foundation (NOF), International Osteoporosis Foundation (IOF), and Amgen’s Bone Health and Advocacy Relations teams convened in London, England at the Royal Academy of Medicine. The purpose of the meeting was to develop a concrete plan for a meaningful collaboration between the two organizations. Back row:… Read more »

NOF Statement on New Treatment Option for Glucocorticoid-Induced Osteoporosis (GIOP) »

| NOF in the News, Osteoporosis in the News

GIOP is the most common form of secondary osteoporosis. In the U.S., more than 10 percent of patients who receive long-term glucocorticoid treatment are diagnosed with a clinical fracture. The U.S. Food and Drug Administration (FDA) has recently approved the use of denosumab for the treatment of glucocorticoid-induced osteoporosis (GIOP) in men and women at… Read more »

NOF Statement on Medicare Part D »

| Advocacy, NOF in the News

Washington, DC – The National Osteoporosis Foundation (NOF) sent the following statement to Members of Congress on the importance of protecting Medicare Part D: NOF is concerned that recent changes to the Medicare Part D program in the Bipartisan Budget Act (BBA) of 2018 opens the door to other potentially harmful changes that could disrupt… Read more »